Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
about
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.Molecular therapies for tuberous sclerosis and neurofibromatosis.Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review.Cardiac fat-containing lesions are common in tuberous sclerosis complex.
P2860
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@en
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@nl
type
label
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@en
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@nl
prefLabel
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@en
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@nl
P50
P1476
Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.
@en
P2093
Jaroslaw Jozwiak
Malgorzata Szperl
P304
P356
10.1016/J.IJCARD.2007.07.152
P407
P577
2007-11-26T00:00:00Z